Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Lancashire Holdings lifts FY ROE guidance after 'resilient' H1

(Sharecast News) - Lancashire Holdings lifted its guidance for full-year return on equity on Wednesday as it hailed a "resilient" first half. In the six months to 30 June, pre-tax profit fell to $118.6m from $213.6m in the same period a year earlier, coming in ahead of a Bloomberg estimate of $113.3. Profit after tax declined to $109.2m from $200.8m.

Gross premiums written rose 5.8% year-on-year to $1.4bn, with insurance revenue up 8.9% to $930.1m.

Assuming a similar second-half loss environment to 2024, Lancashire said it now expects 2025 return on equity to be high teens, up from previous guidance of mid-teens.

Chief executive Alex Maloney said: "Lancashire's performance for the first six months of the year clearly demonstrates the increased resilience within our business model.

"Our strategy to grow at the right time in the cycle means we are better positioned, across various classes and geographies, than ever before. We have developed a robust, diversified and capital-efficient underwriting portfolio that can absorb the impact of significant industry loss events whilst delivering more predictable returns.

"The impact of the wildfires in California in January has been felt across the sector. Estimated industry insured losses are around $40 billion, making it one of the costliest wildfire disasters ever recorded.

"In this context, our strong profit after tax of $109.2m and healthy discounted combined ratio for the period of 87.4% (undiscounted of 97.8%) shows our ability to deliver attractive returns even in a challenging loss environment."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.